Combination Therapy with a Sodium-Glucose Cotransporter 2 Inhibitor and a Dipeptidyl Peptidase-4 Inhibitor Additively Suppresses Macrophage Foam Cell Formation and Atherosclerosis in Diabetic Mice

Lignende værker

• Combination Therapy with a Sodium-Glucose Cotransporter 2 Inhibitor and a Dipeptidyl Peptidase-4 Inhibitor Additively Suppresses Macrophage Foam Cell Formation and Atherosclerosis in Diabetic Mice
  af: Michishige Terasaki, et al.
  Udgivet: (2017-01-01)
• A Dipeptidyl Peptidase-4 Inhibitor Suppresses Macrophage Foam Cell Formation in Diabetic db/db Mice and Type 2 Diabetes Patients
  af: Terasaki, Michishige, et al.
  Udgivet: (2018)
• Amelioration of Hyperglycemia with a Sodium-Glucose Cotransporter 2 Inhibitor Prevents Macrophage-Driven Atherosclerosis through Macrophage Foam Cell Formation Suppression in Type 1 and Type 2 Diabetic Mice
  af: Terasaki, Michishige, et al.
  Udgivet: (2015)
• A Dipeptidyl Peptidase-4 Inhibitor Inhibits Foam Cell Formation of Macrophages in Type 1 Diabetes via Suppression of CD36 and ACAT-1 Expression
  af: Terasaki, Michishige, et al.
  Udgivet: (2020)
• The role of endothelial nitric oxide in the anti-restenotic effects of liraglutide in a mouse model of restenosis
  af: Kushima, Hideki, et al.
  Udgivet: (2017)